Hepatocellular carcinoma

Br J Hosp Med. 1997 Feb;57(3):101-4.

Abstract

Hepatocellular carcinoma is the most common cancer in males. Surgery is the only curative treatment, but is applicable in only 10-15% of patients. Systemic chemotherapy, transarterial embolization or chemo-embolization can only palliate. In the future, selective internal radiation may have a role in downstaging inoperable hepatoma to operable tumour.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular* / epidemiology
  • Carcinoma, Hepatocellular* / etiology
  • Carcinoma, Hepatocellular* / mortality
  • Carcinoma, Hepatocellular* / therapy
  • Embolization, Therapeutic
  • Epidemiologic Factors
  • Ethanol / therapeutic use
  • Humans
  • Incidence
  • Liver Neoplasms* / epidemiology
  • Liver Neoplasms* / etiology
  • Liver Neoplasms* / mortality
  • Liver Neoplasms* / therapy
  • Liver Transplantation
  • Male
  • Prognosis
  • Survival Rate
  • Treatment Outcome

Substances

  • Ethanol